If you are having trouble viewing this email, view online version .

ESE Daily News Alert - 18 June 2021

Diabetes drug may help treat COVID-19

According to a mouse study published in the journal Immunity, the diabetes drug, metformin, may be a new effective treatment for COVID-19 lung inflammation.

Science Daily


Childhood obesity may be associated with brain alterations

Children with obesity have brain alterations which may cause an unhealthy obsession with food, according to a study published in Cerebral Cortex.

News Medical


Pituitary gland aging may be prevented in mice

According to a Belgian study published in PNAS, the aging process of the pituitary gland in mice, due to chronic inflammation, may be slowed down or repaired using stem cell technology.

Science Daily


MP's urge UK Government to make menopausal HRT free

English MP’s hope new legislation will make hormone replacement therapy for menopausal women free on the NHS, following the lead of Scotland and Wales.

Independent


Poor health may lower antibody response to COVID-19 vaccine

Smoking, central obesity or hypertension may lower antibody response following the Pfizer-BioNTech COVID-19 vaccine, according to a study published in Diabetes/Metabolism Research and Reviews.

Healio


Fibre and milk may improve metabolic health in type 2 diabetes

According to a study published in Gut, a diet high in fibre and milk may be associated with favourable gut microbiota and improve metabolic health in type 2 diabetes.

Healio


The European Society of Endocrinology is Europe’s premier learned society promoting research, education and clinical practice in endocrinology for the public benefit and representing doctors and scientists who work in endocrinology. For more information, visit http://www.ese-hormones.org/

This news alert is designed to provide European Society of Endocrinology (ESE) members with a summary of stories on endocrinology currently appearing in the media. The views expressed in the stories featured in this update are not necessarily those of the ESE. The ESE accepts no responsibility for the accuracy or completeness of the material contained in this alert.

If you know of some European media coverage that would be of interest to the ESE membership, please contact the ESE press office.

Please note that the address that sent this email is not monitored and we cannot respond to direct replies.

Stay connected

To unsubscribe, please change your endocrinology news email preferences in the Member Area.

;